Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 689

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 9
Chunk 689
---
company payables via non-cash capital transactions.Note 4 - The Company guaranteed approximately $9.4 billion primarily related to intercompany indebtedness and financial obligations of certain direct and indirect wholly-owned subsidiaries. There were immaterial liabilities required for these guarantees as of December 31, 2024. Note 5 - In February 2024, as part of our existing share repurchase program, we entered into separate accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. to repurchase $3.2 billion of common stock in aggregate. The total number of shares of our common stock repurchased under the agreements was approximately 9.3 million.

FS-6

 THE CIGNA GROUP AND SUBSIDIARIES

SCHEDULE IIVALUATION AND QUALIFYING ACCOUNTS AND RESERVES(In millions)Balance at Beginning of YearCharged (Credited) to Costs and ExpensesCharged (Credited) to Other AccountsOther DeductionsBalance at End of YearDescription2024     Investment asset valuation reservesAvailable-for-sale debt securities$33 $87 $— $(9)$111 Commercial mortgage loans$31 $(1)$— $— $30 Accounts receivable, net$163 $176 $(1)$(152)$186 Deferred tax asset valuation allowance$1,498 $866 $(32)$— $2,332 Reinsurance recoverables $35 $(5)$— $— $30 2023Investment asset valuation reservesAvailable-for-sale debt securities$44 $11 $— $(22)$33 Commercial mortgage loans$21 $10 $— $— $31 Accounts receivable, net$160 $90 $1 $(88)$163 Deferred tax asset valuation allowance $208 $1,286 $4 $— $1,498 Reinsurance recoverables$35 $— $— $— $35 2022Investment asset valuation reservesAvailable-for-sale debt securities$23 $43 $— $(22)$44 Commercial mortgage loans$6 $15 $— $— $21 Accounts receivable, net$126 $99 $— $(65)$160 Deferred tax asset valuation allowance $246 $(13)$(25)$— $208 Reinsurance recoverables$28 $7 $—